An elaborate pathway required for Ras-mediated epigenetic silencing
Open Access
- 25 October 2007
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 449 (7165) , 1073-1077
- https://doi.org/10.1038/nature06251
Abstract
A genome-wide RNAi screen identifies several genes required for Ras-mediated epigenetic silencing that encode cell signalling molecules, chromatin modifiers, transcriptional activators and repressors, and the DNA methyltransferase DNMT1. The conversion of a normal cell to a cancer cell occurs in several steps and typically involves the activation of oncogenes and the inactivation of tumour suppressor and pro-apoptotic genes1. In many instances, inactivation of genes critical for cancer development occurs by epigenetic silencing, often involving hypermethylation of CpG-rich promoter regions2,3. It remains to be determined whether silencing occurs by random acquisition of epigenetic marks that confer a selective growth advantage or through a specific pathway initiated by an oncogene4,5,6. Here we perform a genome-wide RNA interference (RNAi) screen in K-ras-transformed NIH 3T3 cells and identify 28 genes required for Ras-mediated epigenetic silencing of the pro-apoptotic Fas gene. At least nine of these RESEs (Ras epigenetic silencing effectors), including the DNA methyltransferase DNMT1, are directly associated with specific regions of the Fas promoter in K-ras-transformed NIH 3T3 cells but not in untransformed NIH 3T3 cells. RNAi-mediated knockdown of any of the 28 RESEs results in failure to recruit DNMT1 to the Fas promoter, loss of Fas promoter hypermethylation, and derepression of Fas expression. Analysis of five other epigenetically repressed genes indicates that Ras directs the silencing of multiple unrelated genes through a largely common pathway. Last, we show that nine RESEs are required for anchorage-independent growth and tumorigenicity of K-ras-transformed NIH 3T3 cells; these nine genes have not previously been implicated in transformation by Ras. Our results show that Ras-mediated epigenetic silencing occurs through a specific, complex, pathway involving components that are required for maintenance of a fully transformed phenotype.Keywords
This publication has 25 references indexed in Scilit:
- A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencingNature Genetics, 2007
- Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancerNature Genetics, 2006
- LOT1 (ZAC1/PLAGL1) and its family members: Mechanisms and functionsJournal of Cellular Physiology, 2006
- Proteomic analysis of p38α mitogen-activated protein kinase-regulated changes in membrane fractions of RAS-transformed fibroblastsProteomics, 2006
- Evidence for an instructive mechanism of de novo methylation in cancer cellsNature Genetics, 2006
- Epigenetics provides a new generation of oncogenes and tumour-suppressor genesBritish Journal of Cancer, 2006
- Secreted WNT antagonists as tumor suppressors: pro and conFrontiers in Bioscience-Landmark, 2006
- Detection of N-RAS and K-RAS in their active GTP-bound form in acute myeloid leukemia without activatingRASmutationsLeukemia & Lymphoma, 2006
- Regulation of Cancer Cell Survival by Par‐4Annals of the New York Academy of Sciences, 2005
- Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cellsNature Genetics, 2005